NEW YORK (GenomeWeb News) – Dassault Systèmes and Accelrys today announced that they have signed a definitive merger agreement under which Dassault Systèmes will acquire the San Diego-based software company in an all-cash $750 million transaction.

Dassault Systèmes said Thursday that it will make a tender offer to acquire all the outstanding shares of Accelrys common stock for $12.50 per share. Accelrys shares closed at $9.72 in Wednesday trade on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.